Professional Documents
Culture Documents
WACC
WACC
WACC
Novartis (II)
Corporate Finance 1
When do we need WACC?
• Asset appraisals
✓Capital budgeting: NPV
✓Financial accounting
• Company valuation
• M&A proposals
• Stock repurchases
• Performance assessment
• Optimal capital structure
Source: Practitioner’s guide to cost of capital & WACC calculation: EY Switzerland valuation best practice
Corporate Finance 2
To Do...
3. What will be the WACC for the Innovative Medicines and Sandoz
divisions after the spin-off?
Corporate Finance 3
What is WACC?
(After-tax) cost of debt Cost of equity
𝐷 𝐸
𝑊𝐴𝐶𝐶 = 1 − 𝜏 𝑅𝐷 + 𝑅𝐸
𝐷+𝐸 𝐷+𝐸
Weights
Corporate Finance 4
Novartis’ Current WACC
𝐷 𝐸
𝑊𝐴𝐶𝐶 = 1 − 𝜏 𝑅𝐷 + 𝑅𝐸
𝐷+𝐸 𝐷+𝐸
Q: Book values or market values?
• Market values: book values good approximation only if recorded when
✓ Interest rates were similar to today
✓ The firm’s credit rating was similar
Q: What to include in D?
• D in WACC stands for Net Debt = Debt – Cash Surplus
• Hybrid securities (convertible debt…) are considered debt if:
✓they are senior to equity, and
✓non-payment leads to bankruptcy
Corporate Finance 5
Novartis’ Current WACC
𝐷 𝐸
𝑊𝐴𝐶𝐶 = 1 − 𝜏 𝑅𝐷 + 𝑅𝐸
𝐷+𝐸 𝐷+𝐸
Q: How to compute E?
• Private firm:
✓Assume target leverage
✓Estimate with DCF or Multiples
Corporate Finance 6
Novartis’ Current WACC
𝐷 𝐸
𝑊𝐴𝐶𝐶 = 1 − 𝜏 𝑅𝐷 + 𝑅𝐸
𝐷+𝐸 𝐷+𝐸
𝐷 𝐸
= 6.15% → = (1 − 6.15%)
𝐷+𝐸 𝐷+𝐸
Corporate Finance 7
Novartis’ Current WACC
𝐷 𝐸
𝑊𝐴𝐶𝐶 = 1 − 𝜏 𝑅𝐷 + 𝑅𝐸
𝐷+𝐸 𝐷+𝐸
Corporate Finance 8
Novartis’ Current WACC
𝐷 𝐸
𝑊𝐴𝐶𝐶 = 1 − 𝜏 𝑅𝐷 + 𝑅𝐸
𝐷+𝐸 𝐷+𝐸
Q: How to compute cost of debt 𝑹𝑫 ?
𝑹𝑫 = 𝑅𝐹 + 𝐶𝑟𝑒𝑑𝑖𝑡 𝑆𝑝𝑟𝑒𝑎𝑑
where 𝑅𝐹 = Risk-Free Rate
• Credit spread:
✓Represents creditors’ expected compensation over risk-free investment
✓Reflects creditors’ risk of investment
Corporate Finance 9
Novartis’ Current WACC
𝐷 𝐸
𝑊𝐴𝐶𝐶 = 1 − 𝜏 𝑅𝐷 + 𝑅𝐸
𝐷+𝐸 𝐷+𝐸
Q: How to g𝐞𝐭 𝑹𝑫 ?
1. Own traded bonds (yield-to-maturity YTM) to directly determine 𝑅𝐷
2. Credit ratings → 𝑅𝐷 = 𝑅𝐹 + 𝑆𝑝𝑟𝑒𝑎𝑑
✓Use average credit spread of companies with same credit rating
3. Synthetic ratings → 𝑅𝐷 = 𝑅𝐹 + 𝑆𝑝𝑟𝑒𝑎𝑑
✓Use financial ratios to infer rating and credit spread
4. Cost of new bank loans
5. Interest Expenses / Debt (avoid if possible since backward looking)
Corporate Finance 10
Interest Coverage Ratio and Credit Ratings
ICR > ≤ to Rating is Spread is
𝑅𝐷 = 𝑅𝐹 + 𝑆𝑝𝑟𝑒𝑎𝑑 8.5 100000 AAA 0.69%
6.5 8.499 AA 0.85%
5.5 6.499 A+ 1.23% Investment
𝐹𝐼𝑁𝐸𝑋 = 𝑅𝐷 × 𝐷 4.25 5.499 A 1.42% grade bonds
3 4.249 A- 1.62%
2.5 2.999 BBB 2.00%
2.25 2.499 BB+ 2.42%
𝐸𝐵𝐼𝑇 2 2.249 BB 3.13%
𝐼𝐶𝑅 =
𝐹𝐼𝑁𝐸𝑋 1.75 1.999 B+ 4.55%
1.5 1.749 B 5.26%
1.25 1.499 B- 7.37% Junk bonds
CCC 11.57%
↑ 𝑫 ⟹↑ 𝑭𝑰𝑵𝑬𝑿 ⟹↓ 𝑰𝑪𝑹 0.8 1.249
0.65 0.799 CC 15.78%
⟹↑ 𝑺𝒑𝒓𝒆𝒂𝒅 ⟹↑ 𝑹𝑫 0.2 0.649 C 17.50%
-100000 0.199 D 20.00%
Date: January 2023, source: http://pages.stern.nyu.edu/~adamodar/
Non-financial US companies
Corporate Finance 11
Synthetic Ratings
Median financial ratio by credit rating
Moody's Seasoned Aaa and Baa Corporate Bond Yield Relative to Yield on 10-Year Treasury Constant
Maturity, Percent, Daily, Not Seasonally Adjusted. Source: Federal Reserve Bank of St. Louis.
Corporate Finance 13
Novartis’ Current WACC
𝐷 𝐸
𝑊𝐴𝐶𝐶 = 1 − 𝜏 𝑅𝐷 + 𝑅𝐸
𝐷+𝐸 𝐷+𝐸
𝑅𝐷 = 𝑅𝐹 + 𝑺𝒑𝒓𝒆𝒂𝒅
Table 2 Table 1
US Treasury Yields 2023 Maturity Rate Interest Coverage
Business Segments Credit Rating Spread to Treasury
Ratio
1-Year 5.25%
Novartis A1 10.84 0.92%
5-Year 4.62%
Innovative Medicines Aa2 10.96 0.70%
10-Year 4.59%
Sandoz Baa2 8.58 1.47%
30-Year 4.72%
Corporate Finance 14
Novartis’ Current WACC
𝐷 𝐸
𝑊𝐴𝐶𝐶 = 1 − 𝜏 𝑅𝐷 + 𝑅𝐸
𝐷+𝐸 𝐷+𝐸
𝑅𝐷 = 𝑅𝐹 + 𝑺𝒑𝒓𝒆𝒂𝒅
Corporate Finance 15
Novartis’ Current WACC
𝐷 𝐸
𝑊𝐴𝐶𝐶 = 1 − 𝜏 𝑅𝐷 + 𝑅𝐸
𝐷+𝐸 𝐷+𝐸
Q: How to compute cost of equity 𝑅𝐸 ?
𝑅𝐸𝐶𝑢𝑟𝑟𝑒𝑛𝑡 = 𝑅𝐹 + 𝛽𝐸 × 𝑅𝑀 − 𝑅𝐹
Corporate Finance 16
Novartis’ Current WACC
𝐷 𝐸
𝑊𝐴𝐶𝐶 = 1 − 𝜏 𝑅𝐷 + 𝑅𝐸
𝐷+𝐸 𝐷+𝐸
𝑾𝑨𝑪𝑪 = 𝟕. 𝟔𝟗%
Corporate Finance 17
Cost of
𝑅𝐸
capital
7.89%
7.69% 𝑊𝐴𝐶𝐶
𝑅𝐷 (1 − 𝜏)
5.51%(1-17%)
0% 6.15% 100%
𝐷
Current Leverage
𝐷+𝐸
Corporate Finance 18
To Do...
3. What will be the WACC for the Innovative Medicines and Sandoz
divisions after the spin-off?
Corporate Finance 19
New WACC at 30% leverage?
𝐷 𝑁𝑒𝑤
✓ New WACC = 30%, assume 𝑅𝐷𝑁𝑒𝑤 = 5.51%:
𝐷+𝐸
𝐷 𝑁𝑒𝑤 𝐸 𝑁𝑒𝑤
𝑊𝐴𝐶𝐶 𝑁𝑒𝑤 = 1 − 𝜏 𝑅𝐷𝑁𝑒𝑤 + 𝑅𝐸𝑁𝑒𝑤
𝐷+𝐸 𝐷+𝐸
Corporate Finance 20
Cost of 2) Relever 𝑅𝐸
capital
1) Unlever
𝑅𝐴 7.89%
7.69% 𝑊𝐴𝐶𝐶
𝑅𝐷 (1 − 𝜏)
5.51%(1-17%)
𝐸 𝐶𝑢𝑟𝑟𝑒𝑛𝑡
𝐷(1 − 𝜏)
𝑅𝐴 = 𝑅𝐸 + 𝑅𝐷𝐶𝑢𝑟𝑟𝑒𝑛𝑡
𝐸 + 𝐷(1 − 𝜏) 𝐸 + 𝐷(1 − 𝜏)
✓ The cost of assets 𝑅𝐴 is the cost of equity if the firm had no debt
✓ It reflects only the operational risk of the firm, not the financial risk
✓ It is also known as the unlevered cost of capital
Corporate Finance 22
Cost of
𝑅𝐸
capital
1) Unlever
𝑅𝐴 7.89%
7.77%
7.69% 𝑊𝐴𝐶𝐶
𝑅𝐷 (1 − 𝜏)
5.51%(1-17%)
𝐷 𝑁𝑒𝑤
2. Relever 𝑅𝐴 to new target leverage = 30%:
𝐷+𝐸
𝐷𝑁𝑒𝑤
𝑅𝐸𝑁𝑒𝑤 = 𝑅𝐴 + (1 − 𝜏) 𝑅𝐴 − 𝑅𝐷𝑁𝑒𝑤
𝐸
Corporate Finance 24
Useful Trick!
𝐷 𝐷
✓ Trick to get if you have :
𝐸 𝐷+𝐸
𝐷 𝐷 𝑦
=𝑦→ =
𝐷+𝐸 𝐸 1−𝑦
✓ In our case:
𝐷 𝐷 0.3
= 30% → = = 0.43
𝐷+𝐸 𝐸 1 − 0.3
Corporate Finance 25
Steps to compute 𝑅𝐸𝑁𝑒𝑤 : Relevering
𝐷 𝑁𝑒𝑤
2. Relever 𝑅𝐴 to new target leverage = 30%:
𝐷+𝐸
𝐷𝑁𝑒𝑤
𝑅𝐸𝑁𝑒𝑤 = 𝑅𝐴 + (1 − 𝜏) 𝑅𝐴 − 𝑅𝐷𝑁𝑒𝑤
𝐸
= 8.57%
Corporate Finance 26
Cost of 2) Relever 𝑅𝐸
capital
1) Unlever
8.57%
𝑅𝐴 7.89%
7.77%
7.69% 𝑊𝐴𝐶𝐶
???
𝑅𝐷 (1 − 𝜏)
5.51%(1-17%)
𝐷 𝑁𝑒𝑤 𝐸 𝑁𝑒𝑤
𝑊𝐴𝐶𝐶 𝑁𝑒𝑤 = 1 − 𝜏 𝑅𝐷𝑁𝑒𝑤 + 𝑅𝐸𝑁𝑒𝑤
𝐷+𝐸 𝐷+𝐸
Corporate Finance 28
Cost of 2) Relever 𝑅𝐸
capital
1) Unlever
8.57%
𝑅𝐴 7.89%
7.77%
7.69% 𝑊𝐴𝐶𝐶
7.37%
𝑅𝐷 (1 − 𝜏)
5.51%(1-17%)
Corporate Finance 30